David Jeffrey Fear
Thunderbird Partners
David Jeffrey Fear Sarepta Therapeutics Inc stake
total: 82
Thunderbird Partners SRPT trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2022 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2022 Q2
According to 2026 Q2 report, David Jeffrey Fear doesn't hold any Sarepta Therapeutics Inc (SRPT) shares. To date, the estimated cost basis is nearly $78.12 for "buy" trades and estimated average "sell" price is $78.12. Thunderbird Partners first purchased SRPT in 2022 Q1, initially acquiring 224,883 shares. Since the initial investment in Sarepta Therapeutics Inc (SRPT), Thunderbird Partners has made 1 more transaction.
When did David Jeffrey Fear sell Sarepta Therapeutics Inc (SRPT)?
David Jeffrey Fear sold off the entire Sarepta Therapeutics Inc (SRPT) position in 2022 Q2.
When did David Jeffrey Fear buy Sarepta Therapeutics Inc (SRPT)?
David Jeffrey Fear first invested in Sarepta Therapeutics Inc (SRPT) in 2022 Q1 at the reported quarter-end price of $78.12 per share.
What's the cost basis of Thunderbird Partners's SRPT stake?
The estimated cost basis for Sarepta Therapeutics Inc (SRPT) stake is around $78.12 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $78.12
- Weighted AVG sell price:
- $78.12
David Jeffrey Fear's historical trades in Sarepta Therapeutics Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.00%
|
0
|
$78.12
|
|
-100% (-224,883)
|
-2.49%
|
|
2022 Q1
|
2.49%
|
224,883
|
$78.12
|
$17,568,000
|
new
|
+2.49%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.